(Q82837028)
Statements
Vedolizumab for the treatment of active ulcerative colitis: a randomized controlled phase 2 dose-ranging study (English)
Asit Parikh
Timothy Leach
Tim Wyant
Catherine Scholz
Serap Sankoh
Diane R Mould
Terry Ponich
Irving Fox